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A number of studies examining interactions of dendritic cell (DC)-specific ICAM-3 grabbing nonintegrin (DC-SIGN) with viral
pathogens have relied on monocytic transfectants as models for primary DCs. Here we show that the presumed ‘‘THP-1’’ monocytic cells
used in these studies are instead Raji B cells. Moreover, we demonstrate that true THP-1 cells do not support DC-SIGN-mediated HIV-1
transmission, whereas human B cell lines efficiently enhance this process. These data indicate that there are features common to B cells and
DCs that facilitate transmission of HIV-1 and provide new insights toward the mechanism of DC-SIGN-mediated HIV-1 transmission.
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The identification of dendritic cell (DC)-specific
ICAM-3 grabbing nonintegrin (DC-SIGN) as a key me-
diator of DC transmission of human immunodeficiency
virus type 1 (HIV-1) to CD4+ T cells has provided an
important molecular insight into this enigmatic process
(Geijtenbeek et al., 2000a). A defining aspect of DC-
SIGN’s interactions with HIV-1 is that it efficiently
promotes infection in trans. Although it is not currently
understood how the trans donation of HIV from donor to
target cell takes place, DC-SIGN-mediated HIV transmis-
sion can be reconstructed with transformed cell lines
facilitating examination of the underlying mechanism.
To model and better understand DC-SIGN function in
human monocyte-derived DCs (MDDCs), DC-SIGN
transfectants of a cell line presumed to be monocytic
THP-1 cells have been used in several publications to
study interactions with viral pathogens including HIV-1/2,
simian immunodeficiency virus (SIV), cytomegalovirus
(CMV), Ebola virus, and Dengue virus (Baribaud et al.,
2002; Bashirova et al., 2001, 2003; Geijtenbeek et al.,0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2003.09.028
* Corresponding author. Fax: +1-301-846-6777.
E-mail address: vineet@ncifcrf.gov (V.N. KewalRamani).2000a, 2000b; Gummuluru et al., 2002; Halary et al.,
2002; Kwon et al., 2002; Lin et al., 2003; Navarro-
Sanchez et al., 2003; Spear et al., 2003; Tassaneetrithep
et al., 2003; Trumpfheller et al., 2003; Wu et al., 2002a,
2002b). However, in our efforts to define cell types that
were permissive for DC-SIGN-mediated HIV-1 transmis-
sion, we recognized that ‘‘THP-1’’ cells that have been
used in these studies were neither THP-1 cells nor any
other monocytic line. Instead, these cells are derived from
Raji B cells. Significantly, THP-1 monocytes do not
support DC-SIGN-mediated HIV-1 transmission, whereas
Raji B cells and other human B cell lines efficiently
promote this process. These results suggest that previous
studies of DC-SIGN function obtained using the misiden-
tified B cell line need to be carefully reconsidered, and
they also provide important insight into the mechanism of
DC-SIGN-mediated HIV-1 trans infection.Results
B-THP-1 cells are phenotypically and functionally distinct
from THP-1 cells
Here we refer to the misidentified ‘‘THP-1’’ cells as B-
THP-1 cells to reflect their presumed THP-1 origin. Initial
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monocytic cell line did not express endogenous CD4. Be-
cause most monocytic cells express CD4, we examined other
THP-1 cell lines obtained from the ATCC and NCI for CD4
expression. These cells, in contrast, expressed low levels of
CD4 (Table 1). In addition, examination of THP-1ATCC cells
and THP-1NCI revealed that 10–15% of the cells expressed
low levels of endogenously encoded DC-SIGN (Fig. 1A, left
panels). In contrast, B-THP-1 cells and Raji cells, a human B
cell reference line, were uniformly negative for endogenous
expression of DC-SIGN (Fig. 1A, left panels).
To test the ability of these cells to transmit HIV-1
mediated by DC-SIGN, we transduced the B-THP-1, Raji,
THP-1ATCC, and THP-1NCI cells with retroviral vectors
that encoded human DC-SIGN cDNA and obtained stable
cell populations expressing high levels of DC-SIGN (Fig.
1A, right panels). To our surprise, only the B-THP-1/DC-
SIGN and the Raji/DC-SIGN cells efficiently supported
DC-SIGN-mediated HIV-1 transmission, which was en-
hanced nearly 500-fold compared with the parental cellTable 1










CD4   + + ++
CD11b +/ +/ + +
CD11c   + + ++
CD13   + ++ ++ +
CD14   + +/
CD33   + + +
B lineage
CD5 + + + + + +  
CD10 + + + +  
CD19 + + + + + +  
CD20 + + + +  
CD21 + + + + + +/ +/
CD22 + + + + + +  
Other
HLA-DR (MHC II) + + + + + + + +/
CD11a (LFA-1a) + + + + + ++ ++
CD18 (LFA-1h) + + + + + ++ ++
CD34    
CD40 + + + + + + + + ++
CD50 (ICAM-3)   + 
CD54 (ICAM-1) + + + + + + + +
CD58 (LFA-3) + + + + + ++
CD69  +  
CD80 (B7.1) + + + +  
CD83 + + +  
CD86 (B7.2) + + + + +/ +/
CD102 (ICAM-2) + + + + +/
a Expression of each marker was evaluated by cell surface staining with
specific mAbs and compared with isotype-matched IgG controls. Cell
population expression levels indicated as +++, ++, +, and +/
demonstrated a mean fluorescence of antibody staining greater than 250,
50, 10, or 7.5, respectively. Isotype control stainings typically displayed a
mean fluorescence intensity of 5 in the FL-2 channel using a Becton–
Dickinson FACSCalibur instrument.controls (Fig. 1B). Despite similar or higher levels of DC-
SIGN expression present on the THP-1ATCC/DC-SIGN
and THP-1NCI/DC-SIGN cells, these lines did not notice-
ably stimulate transmission of HIV-1 to CD4+ T cells
(Fig. 1B) or GHOST/X4/R5 indicator cells (data not
shown).
The discordance in DC-SIGN-mediated HIV-1 transmis-
sion function exhibited by the different cell lines prompted
further characterization. We examined these cells for the
presence of cell surface markers that distinguish lineages
of hematopoietic cells. All cells were uniformly negative
for CD2, CD3, CD16, and CD40 ligand, indicating that the
B-THP-1 cells are not derived from T or NK cells.
However, only the THP-1ATCC and THP-1NCI cells ex-
pressed other cell surface markers that are consistent with
a monocytic lineage, including CD4, CD11c, CD13,
CD14, and CD33 (Table 1). Instead, we found that B-
THP-1 cells express CD5, CD10, CD19, CD20, CD21,
and CD22, which are consistent with cells of a human B
cell origin. Raji cells were virtually identical to B-THP-1
cells with regards to cell surface markers; whereas B-THP-
1 cells were phenotypically distinct from the THP-1ATCC,
THP-1NCI cells, and other transformed monocytic cell lines
(Table 1 and data not shown). Expression of DC-SIGN in
B-THP-1, THP-1ATCC, THP-1NCI, and Raji cells did not
influence expression of the markers examined in Table 1
(data not shown).
B-THP-1 cells are EBV-positive
Because many immortalized human B cells are trans-
formed with the Epstein–Barr virus (EBV), we assayed for
the presence of EBV in B-THP-1 cells. Diagnostic poly-
merase chain reaction (PCR) analysis for the EBNA1 gene
revealed the presence of EBV in B-THP-1, Raji, and the
human B line NC-37 cells (348-bp product). In contrast, the
EBNA1 gene was not detected in the THP-1 reference lines,
Ramos B cells (an EBV-negative, Burkitt’s lymphoma line,
Klein et al., 1975), or other human non-B cell lines that we
examined including Hut78, Jurkat, HL-60, U937, and K562
cells.
B-THP-1 cells are genotypically identical to Raji cells
To determine whether the numerous phenotypic differ-
ences observed between B-THP-1 cells and reference
THP-1 cell lines reflected a different origin of the cells
or were the result of different experimental manipulation,
we genotypically compared B-THP-1, Raji, THP-1ATCC,
THP-1NCI, NC-37, and Ramos cells. Analysis of the
polymorphic HLA class I loci revealed that THP-1ATCC
and THP-1NCI cells were genetically identical at the three
HLA class I loci, HLA-A, -B, and -C, but were distinct
from B-THP-1, Raji, NC-37, and Ramos cells (Table 2).
In contrast, B-THP-1 and Raji cells were identical by
HLA class I analysis and distinct from two other human
Fig. 1. Characterization of B-THP-1, Raji, and THP-1 lines expressing DC-SIGN. (A) DC-SIGN expression in different donor cell lines. Staining of parental
cell lines (left panel) or DC-SIGN transduced cell lines (right panel) with either murine IgG2b isotypic control antibody (thin line) or mAb 120507 against DC-
SIGN (thick line). The mean fluorescence of DC-SIGN staining is shown in the top right corner of the histograms. (B) Variable efficiency of HIV-1
transmission mediated by different DC-SIGN-expressing cell lines. Capture and transmission of HIV-Luc/ADAwere performed as described (Wu et al., 2002a,
2002b). DC-SIGN-expressing donor cells (black bar) were incubated with HIV-1 for 3 h, and the donor cells were washed before co-culturing with Hut/CCR5
target cells. Parental lines (open bar) were used as donor cell controls. Transmission by the different cell types was examined in parallel to FACS staining
analyses of DC-SIGN expression depicted in panel A. (C) Other human B cells support HIV-1 transmission. Parental lines (open bar) were used as donor cell
controls in the capture and transmission assay described in B. Each data set represents the mean of three separate wells of infected cells. One representative
experiment out of three is shown. cps, counts per second.
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Table 2
HLA class I genotyping of DC-SIGN donor cell linesa
Cell linesb HLA-A HLA-B HLA-C
B-THP-1/DC-SIGN 0301/0301 1510/1510 0304/0401
Raji/DC-SIGN 0301/0301 1510/1510 0304/0401
THP-1ATCC/DC-SIGN 0201/0201 1511/1511 0303/0303
THP-1NCI/DC-SIGN 0201/0201 1511/1511 0303/0303
NC-37/DC-SIGN 0301/2501 2705/4402 0202/0501
Ramos/DC-SIGN 0301/0301 4403/5101 1601/1601
a High resolution HLA-A, -B, and -C genotypes are shown.
b Genotyping results were consistent between parental lines and their DC-
SIGN-expressing derivatives.
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genotyping of highly polymorphic microsatellite DNA
at 10 loci (2-761-5, 2-890.7, 2-995.3, 4-1114.5, 2-1483.7,
2-1683.6, 2-1725.6, 2-1909.4, NP1TT14Z1, NP12B1) and
the killer cell Ig-like receptor (KIR) at five loci (2DL1-5,
2DS1-5, 3DL1-3, 3DS1, KIR2DP1) confirmed that THP-
1ATCC and THP-1NCI cells were identical to one another,
but distinct from B-THP-1 cells, which were identical to
Raji cells (data not shown).
Human B cells support DC-SIGN-mediated HIV-1
transmission
To examine whether other human B cell lines support the
DC-SIGN-mediated HIV-1 transmission, we obtained NC-
37/DC-SIGN and Ramos/DC-SIGN stable transductants and
tested these cells in the HIV-1 transmission assay. Similar to
B-THP-1/DC-SIGN and Raji/DC-SIGN cells, NC-37/DC-
SIGN and Ramos/DC-SIGN were able to transmit HIV-1 to
CD4+ T cells (Fig. 1C). HIV-1 transmission efficiency of the
different B lines correlated with DC-SIGN expression levels
(data not shown). Notably, DC-SIGN-negative NC-37 pa-
rental cells captured and transmitted HIV-1 20-fold better
than the B-THP-1 parental line.Discussion
Our examination of cells previously thought to be the
‘‘THP-1’’ monocytic line (Geijtenbeek et al., 2000a) has
revealed that these cells are actually derived from the Raji
B cell line. Indeed, Raji cells obtained from the ATCC are
phenotypically and genetically indistinguishable from the
B-THP-1 cells. In addition, like B-THP-1/DC-SIGN cells,
human B cell lines such as Raji cells, NC-37, and Ramos
cells engineered to express DC-SIGN potently transmit
HIV-1 to target cells in the co-culture. In marked contrast,
we found that bona fide THP-1 monocytic cells engineered
to express DC-SIGN do not support HIV-1 transmission to
target cells. These results have important implications for
the current DC-SIGN literature that has utilized the mis-
identified cells.
Although prior studies utilizing the misidentified DC-
SIGN transductants often used what were likely matchedparental cells as a control line (Baribaud et al., 2002;
Bashirova et al., 2001, 2003; Geijtenbeek et al., 2000a,
2000b; Gummuluru et al., 2002; Halary et al., 2002;
Kwon et al., 2002; Lin et al., 2003; Navarro-Sanchez et
al., 2003; Spear et al., 2003; Tassaneetrithep et al., 2003;
Trumpfheller et al., 2003; Wu et al., 2002a, 2002b), use
of a B cell line instead of a monocytic cell line could
result in misinterpretation of observed data. B cell phys-
iology differs in important ways from other antigen-
presenting cells. For example, synaptic junctions between
B cells and T cells are qualitatively different from those
that form between monocytes and T cells (Bromley et al.,
2001; Creusot et al., 2002), and B cell signaling pro-
cesses are distinct from those present within monocytic
cells.
As an example, two recent papers using these mis-
identified cells (Navarro-Sanchez et al., 2003; Tassanee-
trithep et al., 2003) concluded that DC-SIGN enhances
Dengue virus infection of human DC. Whereas Dengue
virus is not known to infect THP-1 cells, it does infect
human B cells (Lin et al., 2002). Although use of DC-
SIGN-expressing Raji cells (called Raji cells here on) as a
model system to mimic Dengue virus interactions with
DCs does not invalidate this work, it could affect the
interpretation of these data. Minimally, these results
should now be reconfirmed with other transformed cell
types that express DC-SIGN. The unanticipated use of B
cells may also provide insight regarding other flaviviruses
examined in the later study that were unexpectedly found
to infect ‘‘THP-1’’ parental cells (Navarro-Sanchez et al.,
2003).
Although it is conspicuous that THP-1 monocytes are
unable to support DC-SIGN transmission of HIV-1, our
data suggest that there are properties conserved between
human B cells and primary DCs that are required for
DC-SIGN transmission of HIV-1. In addition to Raji
cells, several other human B cell lines also appear to
be permissive for this transmission process. It was
recently reported that the human B cell line Namalwa
supports DC-SIGN-mediated HIV-1 transmission (Bobardt
et al., 2003). In our report, we observed that NC-37 and
Ramos B cell lines support DC-SIGN-mediated HIV-1
transmission. Because Ramos cells are not infected by
EBV, these data indicate that DC-SIGN transmission of
HIV-1 by B cells does not require EBV transformation.
Significantly, we observed that NC-37 parental cells
appear to possess DC-SIGN-independent mechanisms
for HIV-1 binding and transmission. This transmission
process was not impaired by DC-SIGN monoclonal anti-
bodies or soluble mannan (data not shown) and may
represent an alternative route by which B cells can
capture and transmit HIV-1.
Similar to these observations, primary human B cells
are capable of transmitting immune-complexed HIV-1 to
CD4+ T cells (Jakubik et al., 2000; Moir et al., 2000).
Expression of DC-SIGN in B cell lines presumably
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1 particles. After virus capture, these lines are highly
effective vehicles for HIV-1 transmission to CD4+ cells.
Thus, our data are consistent with previous findings that
suggested that human B cells that complex HIV-1 via
antibody, complement, or other routes may be significant
contributors to the replication and dissemination of HIV-1
in vivo (Jakubik et al., 2000; Moir et al., 2000). It is of
note that follicular dendritic cells (FDC) capture HIV-1
using related mechanisms and are highly proficient in the
transmission of this virus (Burton et al., 2002; Heath et
al., 1995). It will be of interest to compare B cells,
FDCs, and MDDCs to determine whether conserved
mechanisms of cell–cell communication have been co-
opted by HIV-1 for its transmission (McDonald et al.,
2003).
Despite the number of studies using the misidentified
‘‘THP-1’’ cells, many observations obtained with these cells
have in fact extended our understanding of DC-SIGN
function. Significantly, Raji/DC-SIGN transductants appear
to recapitulate the functional behavior of DC-SIGN
expressed on primary MDDCs (Geijtenbeek et al., 2000a,
2000b). Clearly, future studies with Raji/DC-SIGN trans-
fectants should be interpreted in light of their B lineage
origin. There may also be unexpected benefits from the
discovery that B cells expressing DC-SIGN are effective
disseminators of HIV-1 in that examination of the parallels
between B cell and MDDC physiology will further our
understanding of cell-mediated virus transmission and HIV-
1 pathogenesis in vivo.Materials and methods
Cells
‘‘THP-1’’ (B-THP-1) parental cells have been previously
described (Geijtenbeek et al., 2000a). THP-1ATCC cells
(ATCC number TIB-202), Raji cells (ATCC number CCL-
86), and NC-37 cells (ATCC number CCL-214) were
purchased from the American Type Culture Collection
(ATCC, Manassas, VA). THP-1NCI cells were obtained from
the laboratory of Howard Young at the National Cancer
Institute (NCI). Ramos cells were obtained from Catherine
Smith and Amrie Grammer at the National Institute of
Arthritis and Musculoskeletal and Skin Diseases.
Stable DC-SIGN-expressing cell lines derived from pa-
rental B-THP-1, THP-1ATCC, THP-1NCI, Raji, NC-37, and
Ramos cells were generated by transduction of the parental
cells with MX-DC-SIGN retroviral vectors (Wu et al.,
2002b) followed by fluorescence-activated cell sorting
(FACS) to obtain high levels of DC-SIGN expression. The
human embryonic kidney cell line HEK293T, the human T
cell line Hut/CCR5, and HIV indicator GHOST/X4/R5 cell
lines have been previously described (Wu et al., 2002a,
2002b).Antibodies
Fluorescein isothiocyanate (FITC) or phycoerythrin (PE)-
conjugated mouse anti-human mAbs against the following
molecules were used: DC-SIGN (clone 120507) (R&D
Systems, Minneapolis, MN); monocytic makers: CD4,
CD11b, CD11c, CD13, CD14, CD33; B lineage markers:
CD5, CD10, CD19, CD20, CD21, CD22; T cell or NK cell
markers: CD2, CD3, CD16, CD40; and other makers: HLA-
DR (MHC II); CD11a (LFA-1a); CD18 (LFA-1b), CD34,
CD40, CD50 (ICAM-3), CD54 (ICAM-1), CD58 (LFA-3),
CD69, CD80 (B7.1), CD83, CD86 (B7.2), CD102 (ICAM-2)
(mAbs were purchased from Caltag Laboratories, Burlin-
game, CA and BD-PharMingen, San Diego, CA). Detailed
mAb information is available upon request. FACS staining
was performed as previously described (Wu et al., 2002b).
Virus stocks
Single-round infectious, pseudotyped HIV-1 stocks
(HIV-Luc/ADA) were generated by calcium phosphate co-
transfections of HEK293T cells with the proviral vector
plasmid NL-Luc-ER (HIV-Luc) containing a firefly lu-
ciferase reporter gene and an expression plasmid for the R5-
tropic HIV-1ADA envelope glycoprotein as described (Wu et
al., 2002a, 2002b). Viral stocks were evaluated by limiting
dilution on GHOST/X4/R5 cells.
HIV-1 infection assays
HIV-1 capture and transmission assays were performed
as described previously (Wu et al., 2002a, 2002b). In brief,
donor cells (2.5  105) were incubated with 1  105
infectious units of HIV-Luc/ADA in a total volume of 400
Al for 3 h at 37 jC to allow adsorption of the virus. After 3
h, cells were washed with 1 ml of phosphate-buffered saline
(PBS) and co-cultured with Hut/CCR5 target cells (1  105)
in the presence of 10 Ag of polybrene in 1 ml of culture
medium. Cell lysates were obtained 2 days after infection
and analyzed for luciferase activity using a commercially
available assay kit (Promega, Madison, WI).
Genotyping analyses
Genomic DNA prepared with Genomic-tip 20 G (Qia-
gen, Valencia, CA) from different cell lines was genotyped
by sequencing of the HLA class I loci (http://www.ihwg.
org/protocols/protocol.htm). In addition, comparison of
microsatellite DNA at 10 loci with greater than 75%
heterozygosity (Martin et al., 1998) and KIR loci were also
performed as previously described (Martin et al., 2002).
PCR analyses of EBV
PCR amplification of the EBV nuclear antigen 1
(EBNA1) gene using 5V-GGT CGC CGG TGT GTT CGT
L. Wu et al. / Virology 318 (2004) 17–2322ATATGG-3V as a sense primer and 5V-GCG GCA GCC CCT
TCCACCATAG-3Vas an antisense primer was performed as
described (Muschen et al., 2000).Acknowledgments
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